Personalized Liquid Biopsy and its Biopharma Applications

In this webinar, Dr. Jimmy Lin, Chief Scientific Officer will discuss how Natera’s unique approach enables high sensitivity and specificity for ctDNA detection and cost-effectiveness for tumor burden monitoring. Join the webinar to explore the advantages of personalized ctDNA technology and its applications in oncology research, clinical studies, and pharmaceutical development. Register Now